These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


117 related items for PubMed ID: 1279259

  • 1. [Intra-arterial COMPA chemotherapy for invasive bladder cancer].
    Tsujino S, Yamauchi T, Kokuho M, Kobayashi T, Tachibana Y, Sawano S, Kawai T.
    Nihon Hinyokika Gakkai Zasshi; 1992 Oct; 83(10):1640-6. PubMed ID: 1279259
    [Abstract] [Full Text] [Related]

  • 2. [Intraarterial COMPA (cis-diammine-dichloroplatinum (II), vincristine, methotrexate, peplomycin, adriamycin) chemotherapy for bladder cancer].
    Tsujino S, Ito T, Aizawa T, Namiki K, Ohno Y, Yamamoto S, Ishibashi K, Miki M, Yamauchi T, Kawai T.
    Hinyokika Kiyo; 1992 Oct; 38(10):1101-7. PubMed ID: 1282770
    [Abstract] [Full Text] [Related]

  • 3. [Clinical results of IV-compa (cisplatin, vincristine, methotrexate, peplomycin and adriamycin) chemotherapy for advanced urothelial cancer].
    Tsujino S, Ono Y, Yamamoto S, Tsuzuki M, Miki M, Aizawa T, Matsumoto T, Yamauchi T.
    Nihon Hinyokika Gakkai Zasshi; 1995 Jun; 86(6):1164-71. PubMed ID: 7609360
    [Abstract] [Full Text] [Related]

  • 4. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
    Yamauchi T, Hida S, Ooishi K, Okada K, Yoshida O.
    Hinyokika Kiyo; 1985 Jul; 31(7):1093-104. PubMed ID: 2414981
    [Abstract] [Full Text] [Related]

  • 5. Phase II study of a new combined primary chemotherapy regimen, intravenous methotrexate and vincristine and intraarterial adriamycin and cisplatin, for locally advanced urinary bladder cancer: preliminary results.
    Kuroiwa T, Naito S, Hasuo K, Kishikawa T, Masuda K, Kumazawa J.
    Cancer Chemother Pharmacol; 1995 Jul; 35(5):357-63. PubMed ID: 7850915
    [Abstract] [Full Text] [Related]

  • 6. [Low dose COMPE. Cisplatin, vincristine, methotrexate, peplomycin, etoposide chemotherapy for advanced testicular cancer].
    Ueda T, Yamauchi T, Kawai T, Ohono Y, Kawakami S, Yonese J.
    Nihon Hinyokika Gakkai Zasshi; 1994 Apr; 85(4):626-31. PubMed ID: 7514699
    [Abstract] [Full Text] [Related]

  • 7. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II) and adriamycin in urothelial cancer].
    Konami T, Wakabayashi Y, Kim T, Ishida A, Arai Y, Konishi T, Pak K, Takeuchi H, Tomoyoshi T, Watanabe J.
    Hinyokika Kiyo; 1989 Feb; 35(2):231-7. PubMed ID: 2472048
    [Abstract] [Full Text] [Related]

  • 8. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

  • 9. Three-drug combination chemotherapy for advanced urothelial tract carcinoma.
    Ohshima S, Ono Y, Fujita T, Aso Y.
    Cancer Chemother Pharmacol; 1987 Oct; 20 Suppl():S20-3. PubMed ID: 2444354
    [Abstract] [Full Text] [Related]

  • 10. [Intra-arterial chemotherapy for invasive bladder cancer (T2-3N0M0)].
    Maruyama T, Kondoh N, Nojima M, Yamamoto S, Mori Y, Shima H, Kamikonnya N, Hirota S, Nakao N.
    Hinyokika Kiyo; 2006 Jun; 52(6):445-9. PubMed ID: 16848358
    [Abstract] [Full Text] [Related]

  • 11. Primary cisplatin, methotrexate and vinblastine chemotherapy with selective bladder preservation for muscle invasive carcinoma of the bladder: long-term followup of a prospective study.
    de la Rosa F, Garcia-Carbonero R, Passas J, Rosino A, Lianes P, Paz-Ares L.
    J Urol; 2002 Jun; 167(6):2413-8. PubMed ID: 11992048
    [Abstract] [Full Text] [Related]

  • 12. [Combination chemotherapy with methotrexate, vincristine, cisplatinum, cyclophosphamide, adriamycin, and bleomycin (MVP-CAB) for metastatic urothelial cancer].
    Fujii A, Oka N, Miyasaki S, Higuchi A, Itoh N, Okamoto Y, Tanaka H, Hiro-oka K, Shimatani N, Inoue T.
    Nihon Hinyokika Gakkai Zasshi; 1991 Jun; 82(6):932-9. PubMed ID: 1715415
    [Abstract] [Full Text] [Related]

  • 13. [A study of the use of methotrexate, vincristine, cis-platinum, cyclophosphamide, adriamycin, bleomycin (MVP-CAB) in metastatic transitional cell carcinoma].
    Fujii A, Den S, Nakamura I, Ohshima H, Nagata H, Izumi T, Takechi Y, Kawaida T, Kamidono S, Yasuno H.
    Hinyokika Kiyo; 1987 May; 33(5):697-703. PubMed ID: 2444083
    [Abstract] [Full Text] [Related]

  • 14. [Intraarterial chemotherapy via reservoir system for far-advanced bladder and prostate cancer].
    Takahashi Y, Yamamoto N, Deguchi T, Kuriyama M, Yoh M, Yasuda M, Nakano M, Kawada Y, Takeuchi T, Shinoda I.
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1310-3. PubMed ID: 9703815
    [Abstract] [Full Text] [Related]

  • 15. [Intraarterial chemotherapy with bladder preservation in patients with invasive bladder carcinoma].
    Shiba M, Takatera H, Fujii T, Tokizane T, Shimizu K, Tushima J.
    Hinyokika Kiyo; 2004 Jan; 50(1):15-9. PubMed ID: 15032009
    [Abstract] [Full Text] [Related]

  • 16. [Combination chemotherapy of urothelial cancer with cisplatin, cyclophosphamide, doxorubicin and peplomycin: treatment of advanced cases and adjuvant chemotherapy after radical operation].
    Seguchi T, Sakaguchi H, Kajikawa H, Nishioka T.
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):600-5. PubMed ID: 2435245
    [Abstract] [Full Text] [Related]

  • 17. [Combination chemotherapy with methotrexate (MTX), vincristine (VCR), cisplatinum (CDDP), cyclophosphamide (CPM), adriamycin (ADM), and bleomycin (BLM); MVP-CAB in patients with advanced urothelial tract cancer].
    Fujii A, Morishita S, Nakamura I, Oka Y, Ohshima H, Nagata H, Iwamoto T, Izumi T, Miyasaki Z, Ito N.
    Nihon Hinyokika Gakkai Zasshi; 1988 Jun; 79(6):985-93. PubMed ID: 2460657
    [No Abstract] [Full Text] [Related]

  • 18. [Intra-arterial chemotherapy with cisplatin in advanced urothelial cancer].
    Takahashi Y, Uno H, Nagai T, Tamaki M, Nagatani Y, Shinoda I, Takeuchi T, Fujihiro S, Kuriyama M, Kawada Y.
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2806-9. PubMed ID: 2782890
    [Abstract] [Full Text] [Related]

  • 19. [Means of effective and practical intra-arterial chemotherapy for locally invasive bladder cancer--with special reference to clinical analysis of bladder cancer patients treated by intermittent intra-arterial infusion using an implantable port system].
    Takashima S, Nakamura K, Nakatsuka H, Ogawa R, Kobashi S, Kaminou T, Matsuoka T, Yamada R, Ezaki K, Wada S, Kishimoto T.
    Hinyokika Kiyo; 1999 Feb; 45(2):127-31. PubMed ID: 10212787
    [Abstract] [Full Text] [Related]

  • 20. [Neoadjuvant chemoradiotherapy in locally invasive transitional cell carcinoma of the urinary bladder: early results of PVB and CAP therapy].
    Momose H, Arai K, Nakagawa Y, Fujimoto K, Tsujimoto S, Cho M, Tani Y, Saka M, Nakatsuji F, Iwai A.
    Hinyokika Kiyo; 1989 May; 35(5):781-8. PubMed ID: 2478001
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.